|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #redirect [[IMPROVE score]] |
| {{CMG}}; {{AE}} {{SSH}}, {{SMP}}, {{Anmol}}
| |
| ==Overview==
| |
| The IMPROVE score for venous thromboembolism (VTE) assesses the risk of VTE among hospitalized medical patients.
| |
| ==IMPROVE Score Calculator==
| |
| === Calculation of the IMPROVE Score for VTE ===
| |
| The IMPROVE score for venous thromboembolism (VTE) assesses the risk of VTE among hospitalized medical patients.<ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241 }} </ref> Check all boxes that apply to your patient:
| |
| {{#widget:IMPROVEScore}}
| |
| ===Interpretation of the IMPROVE Score for VTE===
| |
| The interpretation of the score is as follows:
| |
| * Score = 0: Predicted VTE risk through 3 months is 0.4%
| |
| * Score = 1: Predicted VTE risk through 3 months is 0.6%
| |
| * Score = 2: Predicted VTE risk through 3 months is 1%
| |
| * Score = 3: Predicted VTE risk through 3 months is 1.7%
| |
| * Score = 4: Predicted VTE risk through 3 months is 2.9%
| |
| * Score ≥ 5: Predicted VTE risk through 3 months is 7.2%
| |
| ==References==
| |
| {{Reflist|2}}
| |
| [[Category:Medicine]]
| |
| [[Category:Cardiology]]
| |
| [[Category:Hematology]]
| |
| [[Category:Up-To-Date]]
| |
| [[Category:Primary care]]
| |
| [[Category:Calculator]]
| |